3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Lung Neoplasms
18
Hematologic Neoplasms
10
Prostatic Neoplasms
9
Colorectal Neoplasms
9
Breast Neoplasms
9
Hematopoietic and Lymphatic System Neoplasm
8
Carcinoma, Non-Small-Cell Lung
7
Anatomic Stage I Breast Cancer AJCC v8
7
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Ovarian Neoplasms
4
Neoplasms
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Carcinoma
4
Breast Carcinoma In Situ
4
Triple Negative Breast Neoplasms
3
Multiple Myeloma
3
Melanoma
3
Malignant Solid Neoplasm
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Carcinoma, Renal Cell
3
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Papillomavirus Infections
2
Mouth Neoplasms
2
Head and Neck Neoplasms
2
Interventions
Specimen Handling
8
pembrolizumab
7
enfortumab vedotin
7
Magnetic Resonance Spectroscopy
6
Nivolumab
4
avelumab
3
Gemcitabine
3
cabozantinib
2
Ipilimumab
2
Immunoglobulin G
2
Disulfides
2
Cisplatin
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
vinflunine
1
tremelimumab
1
tocilizumab
1
tamibarotene
1
relatlimab
1
eribulin
1
erdafitinib
1
durvalumab
1
atezolizumab
1
Watchful Waiting
1
Standard of Care
1
Propranolol
1
Practice Guidelines as Topic
1
Plasmapheresis
1
Plasma Exchange
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ureteral Neoplasms
×
Practice Guidelines as Topic
×
1 year
×
Clear all
NCT07087860
2026-05-08
RECIPE-B1
Mayo Clinic
Phase 2
Recruiting
70 enrolled